Latest International Expansion News

IPH Limited has appointed Tony O’Malley as its new CEO starting July 2026, bringing over 30 years of global legal and professional services experience, including AI-driven transformation expertise.

Zoono Group has secured its first major commercial orders worth NZ$600,000 from Sharpak under an exclusive UK soft fruits packaging contract, marking a key step in scaling its antimicrobial coating technology in international markets.

Qoria Limited is moving towards a transformative merger with US-based Aura Consolidated Group, Inc., combining complementary digital safety platforms and targeting growth through a $100 million capital raise and ASX listing.

Biome Australia has launched a multi-centre clinical trial for its proprietary probiotic BMB18, adding a prestigious Greek university to its research network and commencing recruitment within the expected timeline.

Eagers Automotive delivered record $13 billion revenue and underlying EBITDAI of $620.9 million in 2025, boosted by strategic investments in CanadaOne Auto and Mitsubishi Corporation. The company’s 2026 outlook is positive, supported by strong order books and easing supply constraints.

XReality Group (ASX:XRG) posts strong FY26 revenue and ARR growth, marking key milestones with its first commercial MR-1 mixed reality sale to the US Department of Defense and debut European contract with the Swedish Armed Forces.

KMD Brands delivered steady sales growth and margin improvement in Q3 FY26, driven by Kathmandu and Rip Curl, while launching a business review to explore options for accelerating shareholder value.

SPC Global has launched a fully underwritten entitlement offer to raise approximately $97.1 million at 10 cents per share, aiming to reduce debt and support working capital.

Guzman y Gomez has abruptly exited the US market, citing financial underperformance despite brand progress, while reaffirming strong Australian growth and international franchise confidence.

AFT Pharmaceuticals posted a 22% revenue jump to NZ$254.7 million and a 39% increase in operating profit to a record NZ$24.4 million for FY26, exceeding guidance. The company targets over NZ$300 million revenue for FY27, fueled by international expansion and a deepening R&D pipeline.

RAS Technology Holdings has locked in new contracts and extensions expected to add at least $2 million in annualised revenue, reinforcing growth in wagering technology and international markets.

BCAL Diagnostics has embedded referral forms for its early cancer detection tests into clinical software used by 97% of Australian GPs, launched a telehealth platform, and opened a Sydney clinic, gearing up for a multi-cancer test launch in June 2026.